National trends in the outpatient treatment of depression

被引:601
作者
Olfson, M
Marcus, SC
Druss, B
Elinson, L
Tanielian, T
Pincus, HA
机构
[1] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA
[2] Univ Penn, Sch Social Work, Philadelphia, PA 19104 USA
[3] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
[4] NIOSH, Pittsburgh Res Lab, Pittsburgh, PA USA
[5] RAND Corp, Pittsburgh, PA USA
[6] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 287卷 / 02期
关键词
D O I
10.1001/jama.287.2.203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Recent advances in pharmacotherapy and changing health care environments have focused increased attention on trends in outpatient treatment of depression. Objective To compare trends in outpatient treatment of depressive disorders in the United States in 1987 and 1997. Design and Setting Analysis of service utilization data from 2 nationally representative surveys of the US general population, the 1987 National Medical Expenditure Survey (N=34459) and the 1997 Medical Expenditure Panel Survey (N=32636). Participants Respondents who reported making 1 or more outpatient visits for treatment of depression during that calendar year. Main Outcome Measures Rate of treatment, psychotropic medication use, psychotherapy; number of outpatient treatment visits, type of health care professional, and source of payment. Results The rate of outpatient treatment for depression increased from 0.73 per 100 persons in 1987 to 2.33 in 1997 (P<.001). The proportion of treated individuals who used antidepressant medications increased from 37.3% to 74.5% (P<.001), whereas the proportion who received psychotherapy declined (71.1% vs 60.2%, P=.006). The mean number of depression treatment visits per user declined from 12.6 to 8.7 per year (P=.05). An increasingly large proportion of patients were treated by physicians for their condition (68.9% vs 87.3%, P<.001), and treatment costs were more often covered by third-party payers (39.3% to 55.2%, P<.001). Conclusions Between 1987 and 1997, there was a marked increase in the proportion of the population who received outpatient treatment for depression. Treatment became characterized by greater involvement of physicians, greater use of psychotropic medications, and expanding availability of third-party payment, but fewer outpatient visits and less use of psychotherapy. These changes coincided with the advent of better-tolerated antidepressants, increased penetration of managed care, and the development of rapid and efficient procedures for diagnosing depression in clinical practice.
引用
收藏
页码:203 / 209
页数:7
相关论文
共 42 条
[1]  
[Anonymous], 2000, Am J Psychiatry, V157, P1
[2]  
BLAZER DG, 1994, AM J PSYCHIAT, V151, P979
[3]  
COHEN S, 1991, 910037 AHCPR
[4]  
COHEN SB, 2000, 010001 AHRQ
[5]   Quality of care and cost-containment in managed mental health: Policy, education, research, advocacy [J].
Dana, RH ;
Conner, MG ;
Allen, J .
PSYCHOLOGICAL REPORTS, 1996, 79 (03) :1395-1422
[6]  
*DEPR GUID PAN, 1993, 930551 AHCPR, V2
[7]  
EDWARDS WS, 1989, US DHHS PHS893450
[8]  
Frank RG, 1996, ARCH GEN PSYCHIAT, V53, P933
[9]   MARKETING MIND MECHANICS - DECODING ANTIDEPRESSANT DRUG ADVERTISEMENTS [J].
GOLDMAN, R ;
MONTAGNE, M .
SOCIAL SCIENCE & MEDICINE, 1986, 22 (10) :1047-1058
[10]   Treatment for depression following the 1996 National Depression Screening Day [J].
Greenfield, SF ;
Reizes, JM ;
Muenz, LR ;
Kopans, B ;
Kozloff, RC ;
Jacobs, DG .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (11) :1867-1869